Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 408459, 9 pages
http://dx.doi.org/10.1155/2014/408459
Research Article

Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma

1Institute of Pathology, University Hospital, Krankenhausstr 8–10, Erlangen 91054, Germany
2Department of Gynecology and Obstetrics, University Hospital, Universitätsstr 21, Erlangen 91054, Germany

Received 2 December 2013; Accepted 12 January 2014; Published 19 February 2014

Academic Editor: Gottfried E. Konecny

Copyright © 2014 David L. Wachter et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Eisemann, A. Waldmann, and A. Katalinic, “Epidemiology of breast cancer-current figures and trends,” Geburtsh Frauenheilk, vol. 73, no. 2, pp. 130–135.
  2. F. Feyrter and G. Hartmann, “On the carcinoid growth form of the carcinoma mammae, especially the carcinoma solidum (gelatinosum) mammae],” Frankfurter Zeitschrift für Pathologie, vol. 73, pp. 24–39, 1963. View at Google Scholar · View at Scopus
  3. S. R. Lakhani, I. Ellis, S. Schnitt et al., WHO Classification of Tumours of the Breast. International Agency For Research on Cancer, IARC Press, Lyon, France, 2012.
  4. C. M. Perou, T. Sørile, M. B. Eisen et al., “Molecular portraits of human breast tumours,” Nature, vol. 406, no. 6797, pp. 747–752, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Sørlie, C. M. Perou, R. Tibshirani et al., “Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 19, pp. 10869–10874, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Rouzier, C. M. Perou, W. F. Symmans et al., “Breast cancer molecular subtypes respond differently to preoperative chemotherapy,” Clinical Cancer Research, vol. 11, no. 16, pp. 5678–5685, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Weigelt, F. C. Geyer, H. M. Horlings, B. Kreike, H. Halfwerk, and J. S. Reis-Filho, “Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type,” Modern Pathology, vol. 22, no. 11, pp. 1401–1414, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Wei, T. Ding, Y. Xing et al., “Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma,” Cancer, vol. 116, no. 19, pp. 4463–4473, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. J. Shin, R. A. DeLellis, and P. P. Rosen, “Small cell carcinoma of the breast—additional immunohistochemical studie,” American Journal of Surgical Pathology, vol. 25, no. 6, pp. 831–832, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. M. C. U. Cheang, S. K. Chia, D. Voduc et al., “Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer,” Journal of the National Cancer Institute, vol. 101, no. 10, pp. 736–750, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Sapino, L. Righi, P. Cassoni, M. Papotti, P. Gugliotta, and G. Bussolati, “Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women,” Modern Pathology, vol. 14, no. 8, pp. 768–776, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Kawasaki, K. Mochizuki, H. Yamauchi et al., “Neuroendocrine cells associated with neuroendocrine carcinoma of the breast: nature and significance,” Journal of Clinical Pathology, vol. 65, pp. 699–703, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Righi, A. Sapino, C. Marchiò, M. Papotti, and G. Bussolati, “Neuroendocrine differentiation in breast cancer: established facts and unresolved problems,” Seminars in Diagnostic Pathology, vol. 27, no. 1, pp. 69–76, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Aparicio and C. Caldas, “The implications of clonal genome evolution for cancer medicine,” The New England Journal of Medicine, vol. 368, pp. 842–851, 2013. View at Publisher · View at Google Scholar
  15. F. T. Bosman, F. Carneiro, R. H. Hruban, and N. D. Theise, WHO Classification of Tumours of the Digestive System, World Health Organization, 2010.
  16. H. Nassar, H. Qureshi, N. V. Adsay, and D. Visscher, “Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas,” American Journal of Surgical Pathology, vol. 30, no. 4, pp. 501–507, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Melcher, C. Scholz, B. Jäger, C. Hagenbeck, B. Rack, and W. Janni, “Breast cancer: state of the art and new findings,” Geburtshilfe und Frauenheilkunde, vol. 72, no. 3, pp. 215–224, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Schmidt, P. Fasching, M. Beckmann, and H. Kãibl, “Biomarkers in breast cancer-an update,” Geburtsh Frauenheilk, vol. 72, no. 9, pp. 819–832, 2012. View at Google Scholar
  19. H. C. Rischke, E. Staib-Sebler, S. Mose et al., “Metatasizing carcinoma of the breast with neuroendocrine differentiation: combined treatment with tamoxifen and octreotide,” Deutsche Medizinische Wochenschrift, vol. 124, no. 7, pp. 182–186, 1999. View at Google Scholar · View at Scopus